Background illustration for clinical trials search

Paid Clinical Trials Jersey City

Discover 1,567 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,567

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for

Endometrial Cancer, Recurrent or Progressive Endometrial Cancer

Location: New York NY, Teaneck NJ, Summit NJ, Morristown NJ,

Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07166094

Phase3, Recruiting

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for

Ovarian Cancer

Location: New York NY, Hackensack NJ, Hershey PA, Worcester MA,

Sponsor: Incyte Corporation

Sex: Female

Age: 18 - 70+

Code: NCT07023627

Phase2, Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

for

Endometrial Cancer, Cervical Cancer, Ovarian Cancer,

Location: New York NY, Mineola NY, East Brunswick NJ, Boston MA,

Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT06293898

Phase1, Recruiting

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

for

Cutaneous Melanoma, Stage II

Location: New York NY, Livingston NJ, Lake Success NY, Mineola NY,

Sponsor: Melanoma and Skin Cancer Trials Limited

Sex: All

Age: 18+

Code: NCT03860883

Recruiting

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

for

Multiple Myeloma

Location: New York NY, Mineola NY, New Brunswick NJ,

Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05828511

Phase1, Phase2, Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for

Triple Negative Breast Cancer

Location: New York NY, Summit NJ, Lake Success NY,

Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase3, Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for

Advanced Breast Cancer

Location: New York NY, Brooklyn NY, Mineola NY, East Brunswick NJ,

Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06638307

Phase1, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Location: New York NY, Brooklyn NY, Paramus NJ, Lake Success NY,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase3, Recruiting

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

for

Endometrial Adenocarcinoma

Location: New York NY, Hackensack NJ, New Brunswick NJ,

Sponsor: Acrivon Therapeutics

Sex: Female

Age: 18+

Code: NCT05548296

Phase2, Recruiting

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

for

Locoregional Recurrence,

Location: New York NY, New Brunswick NJ, Hershey PA, Boston MA,

Sponsor: Oana Danciu

Sex: All

Age: 18+

Code: NCT05467891

Phase2, Recruiting

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

for

Non-alcoholic Fatty Liver Disease

Location: New York NY, Jersey City NJ, East Syracuse NY,

Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07221188

Phase3, Recruiting

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

for

Lennox Gastaut Syndrome

Location: New York NY, Marlboro NJ, Philadelphia PA, Durham NC,

Sponsor: Epygenix

Sex: All

Age: 2 - 55

Code: NCT05066217

Phase3, Recruiting

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

for

Solid Tumor

Location: New York NY, Hackensack NJ, Newark DE, Providence RI,

Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT05584670

Phase1, Phase2, Recruiting

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for

Pulmonary Hypertension Due to Lung Diseases and Hypoxia,

Location: New York NY, New Hyde Park NY, Morristown NJ,

Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT06388421

Recruiting

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

for

Refractory Angina

Location: New York NY, Hackensack NJ, Roslyn NY, New Haven CT,

Sponsor: Shockwave Medical, Inc.

Sex: All

Age: 18+

Code: NCT05102019

Recruiting

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

for

Pulmonary Embolism

Location: New York NY, Newark NJ, Philadelphia PA, Wynnewood PA,

Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT05591118

Phase3, Recruiting

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

for

Venous Thromboembolism, Deep Venous Thrombosis,

Location: New York NY, Brooklyn NY, Bay Shore NY, New Haven CT,

Sponsor: Inari Medical

Sex: All

Age: 18+

Code: NCT05701917

Recruiting

A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel

for

Hypogonadism

Location: New York NY, Garden City NY, Edison NJ,

Sponsor: Acerus Pharmaceuticals Corporation

Sex: Male

Age: 18 - 70+

Code: NCT04976595

Recruiting

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

for

Carcinoma, Non-Small-Cell Lung

Location: New York NY, New Brunswick NJ, New Haven CT,

Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All

Age: 18+

Code: NCT06667908

Phase2, Recruiting

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

for

Advanced Solid Tumor, Unresectable Solid Tumor,

Location: New York NY, Hackensack NJ, Philadelphia PA,

Sponsor: Clasp Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06778863

Phase1, Recruiting

Paid Clinical Trials Jersey City

Filter results

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

Interested in new trials?

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation